← Eichor
Study identifier: NCT07245732 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares

Condition: Rheumatoid Arthritis (RA)  ·  Sponsor: Sunnybrook Health Sciences Centre

PhasePhase 4
Planned participants220
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

People living with rheumatoid arthritis (RA) often experience flares-periods where their symptoms suddenly get worse. These flares can cause significant pain, make it harder to move and do daily activities, and lower overall quality of life. Doctors often treat flares with medications called glucocorticoids (GCs), which reduce inflammation. These medications can be taken by mouth (oral/PO) or given as a single injection into the muscle (intramuscular/IM). However, it's not clear which option works better from the patient's point of view-especially when it comes to relief of symptoms, improvements in function, and satisfaction with treatment. Most research so far has focused on how well the drugs control the disease, rather than how they impact the patient's overall experience. Research Questions: 1. Does a single GC injection work just as well as taking pills over a few weeks in improving symptoms reported by patients? 2. How do the two treatments compare in terms of symptom relief, ability to function, and patient satisfaction? 3. What do patients think and feel about using GCs to treat RA flares? What the Investigators Think: The investigators believe that a one-time GC injection is just as good as taking pills for a few weeks when it comes to managing RA flares. In fact, the injection might even be safer and preferred by patients. What the Investigators are Doing: The investigators will study 220 adults with RA who are currently having a flare (with at least 3 swolle…

This description comes directly from the study's public registry record.

Talk to the study team

Timothy S.H. Kwok, MD, MSc, FRCPC  ·  416-480-4580  ·  timothysh.kwok@utoronto.ca

Bindee Kuriya, MD, SM, FRCPC  ·  (416) 586-4800  ·  bindee.kuriya@sinaihealth.ca

Always discuss trial participation with your own doctor first.

Locations (5)

Sunnybrook Health Sciences CentreToronto, Ontario, CanadaRecruiting
St. Michael's HospitalToronto, Ontario, CanadaRecruiting
Women's College HospitalToronto, Ontario, CanadaRecruiting
Toronto Western HospitalToronto, Ontario, CanadaRecruiting
Mount Sinai HospitalToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07245732